Indication
Epidermolysis bullosa
Epidermolysis bullosa encompasses a heterogeneous group of rare, predominantly inherited mechanobullous disorders defined by marked epithelial fragility of the skin and mucous membranes. Read more about Epidermolysis bullosa
2 drugs 2 manufacturers
Drugs that treat it
Common Epidermolysis bullosa therapies.
FILSUVEZ (birch bark extract)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonEpidermolysis bullosa encompasses a heterogeneous group of rare, predominantly inherited mechanobullous disorders defined by marked epithelial fragility of the skin and mucous membranes.
Pathophysiologically, genetic mutations disrupt structural adhesion proteins within the epidermis or basement membrane zone, impairing tolerance to mechanical shearing forces.
This structural defect leads to separation of tissue layers, resulting in painful blister formation, erosions, and chronic ulcerations provoked by minimal friction or minor trauma.
Although clinical severity ranges widely, presentation typically manifests in neonates or infants and can progress to severe complications, including extensive scarring, joint contractures, esophageal strictures, chronic infections, and an elevated risk of aggressive squamous cell carcinoma.
- nih.gov
Epidermolysis bullosa encompasses a heterogeneous group of rare, predominantly inherited mechanobullous disorders defined by marked epithelial fragility of the skin and mucous membranes Pathophysiologically, genetic mutations disrupt structural adhesion proteins within the epidermis or basement membrane zone, impairing tolerance to mechanical shearing forces This structural defect leads to separation of tissue layers, resulting in painful blister formation, erosions, and chronic ulcerations prov...
- merckmanuals.com
Epidermolysis bullosa encompasses a heterogeneous group of rare, predominantly inherited mechanobullous disorders defined by marked epithelial fragility of the skin and mucous membranes Pathophysiologically, genetic mutations disrupt structural adhesion proteins within the epidermis or basement membrane zone, impairing tolerance to mechanical shearing forces Although clinical severity ranges widely, presentation typically manifests in neonates or infants and can progress to severe complications,...
- medlineplus.gov
This structural defect leads to separation of tissue layers, resulting in painful blister formation, erosions, and chronic ulcerations provoked by minimal friction or minor trauma
- medlineplus.gov
Although clinical severity ranges widely, presentation typically manifests in neonates or infants and can progress to severe complications, including extensive scarring, joint contractures, esophageal strictures, chronic infections, and an elevated risk of aggressive squamous cell carcinoma
Personalize your experience
Follow Epidermolysis bullosa and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.